Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATEZO-BRAIN
2017-005154-11Phase 2Completed
- Sponsor
- Fundación GECP
- Start
- May 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab, carboplatin, pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Fundación GECP. Started May 2018; status: completed.
02
Drugs
atezolizumabcarboplatinpemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2017-005154-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005154-11.